🇩🇪 Germany
🇭🇺 Hungary
🇵🇱 Poland
🇪🇸 Spain
🇹🇷 Turkey
Approximately 130 patients will participate in different stages of the study, receiving the vaccine in combination with standard immunotherapies to evaluate both its safety and effectiveness.
The multinational approach enables researchers to gather diverse demographic and genetic data, while also testing the vaccine’s efficacy across various healthcare systems. Additionally, multicenter trials allow for faster preliminary results, helping guide future research and optimize dosing.
Phases of Clinical Trials
Clinical trials typically progress through several phases before a new treatment receives approval from health authorities:
✔ Phase I: Conducted with a small group of patients to evaluate safety and determine the optimal dosage. Potential side effects and tolerance profiles are analyzed.
✔ Phase II: A larger group of patients receives the vaccine to determine preliminary efficacy while continuing to gather safety data. This phase establishes optimal dosing and eligibility criteria.
✔ Phase III: The vaccine is compared with standard treatments, involving a larger number of participants to determine definitive efficacy, large-scale side effects, and benefit-risk balance.
✔ Phase IV: After approval, the vaccine undergoes post-market surveillance to detect rare adverse effects and assess its **
CONTINUE READING ON THE NEXT PAGE 🥰💕
